IQVIA’s Vigilance Signal Detection platform enhances pharmacovigilance by enabling early identification, assessment, and management of drug safety signals. Combining advanced analytics, automation, and real-world data, it provides end-to-end capabilities from data ingestion to visualization and regulatory submission. Features include disproportionality analysis, trend monitoring, signal validation, and workflow automation, ensuring compliance with ICH and FDA requirements. The system integrates with existing safety databases, supports collaboration across teams, and delivers interactive dashboards for better decision-making. With its global reach and therapeutic expertise, IQVIA helps biopharma organizations strengthen safety monitoring, reduce risk, and protect patient well-being.

Join for free to read